Many patients with dystonia or spasticity who receive botulinum neurotoxin type A (BoNT/A) develop neutralizing antibodies (NABs) to the toxin over time, new research shows. NABs against BoNT/A occur ...

Medical education and research, diversity in medicine, women in medicine, community engagement and health equity, clinical trials, treatment of rare neurologic disorders, spasticity and dystonia.

VANCOUVER — The American Academy of Neurology (AAN) has released a new guideline looking at the use of botulinum neurotoxins for the treatment of blepharospasm, cervical dystonia, adult spasticity, ...

International survey presented at TOXINS 2019 reveals hidden burden of spasticity 1 PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today presents at TOXINS, results from an ...

Dystonia is a condition that causes involuntary or unusual movements. There are several different types of dystonia. Focal dystonia affects a single body part, which is usually the fingers or hands.

The American Academy of Neurology (AAN) has updated its guidelines on the use of botulinum neurotoxins in neurological disorders. The new guidelines provide individual recommendations for the four ...

Tardive dyskinesia and dystonia are movement disorders with different causes and onset of symptoms. Treatment for both disorders may involve anticholinergic and benzodiazepine drugs. It's possible to ...

14 abstracts will be presented across a range of neurological conditions including post-stroke spasticity, cervical dystonia, blepharospasm and other movement disorders Interim data from the ongoing ...